Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 934065, 7 pages
http://dx.doi.org/10.1155/2015/934065
Research Article

Liver Failure Impairs the Intrahepatic Elimination of Interleukin-6, Tumor Necrosis Factor-Alpha, Hepatocyte Growth Factor, and Transforming Growth Factor-Beta

1Transplantation Institute, Department of Immunology, Transplantology and Internal Diseases, Medical University of Warsaw, 59 Nowogrodzka Street, 02-006 Warsaw, Poland
2Department of Nephrological Nursing, Medical University of Warsaw, 8 Oczki Street, 02-007 Warsaw, Poland
3Transplantation Institute, Department of General and Transplant Surgery, Medical University of Warsaw, 59 Nowogrodzka Street, 02-006 Warsaw, Poland

Received 29 January 2015; Revised 23 April 2015; Accepted 27 April 2015

Academic Editor: Kusum Kharbanda

Copyright © 2015 Dawid Porowski et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. A. Girón-González, C. Martínez-Sierra, C. Rodriguez-Ramos et al., “Implication of inflammation-related cytokines in the natural history of liver cirrhosis,” Liver International, vol. 24, no. 5, pp. 437–445, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. G. L. A. Bird, N. Sheron, A. K. Goka et al., “Increased plasma tumor necrosis factor in alcoholic hepatitis,” Annals of Internal Medicine, vol. 112, pp. 917–920, 1990. View at Google Scholar
  3. B. Byl, I. Roucloux, A. Crusiaux, E. Dupont, and J. Devière, “Tumor necrosis factor α and interleukin 6 plasma levels in infected cirrhotic patients,” Gastroenterology, vol. 104, no. 5, pp. 1492–1497, 1993. View at Google Scholar · View at Scopus
  4. Y. Muto, K. T. Nouri-Aria, A. Meager, G. J. M. Alexander, A. L. W. F. Eddleston, and R. Williams, “Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure,” The Lancet, vol. 2, no. 8602, pp. 72–74, 1988. View at Google Scholar · View at Scopus
  5. A. L. Brown, D. E. Graham, S. P. Nissley, D. J. Hill, A. J. Strain, and M. M. Rechler, “Developmental regulation of insulin-like growth factor II mRNA in different rat tissues,” Journal of Biological Chemistry, vol. 261, no. 28, pp. 13144–13150, 1986. View at Google Scholar · View at Scopus
  6. K. J. Busam, T. M. Bauer, J. Bauer, W. Gerok, and K. Decker, “Interleukin-6 release by rat liver macrophages,” Journal of Hepatology, vol. 11, no. 3, pp. 367–373, 1990. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Decker, “Biologically active products of stimulated liver macrophages (Kupffer cells),” European Journal of Biochemistry, vol. 192, no. 2, pp. 245–261, 1990. View at Publisher · View at Google Scholar · View at Scopus
  8. D. B. Magilavy and J. L. Rothstein, “Spontaneous production of tumor necrosis factor α by Kupffer cells of MRL/lpr mice,” Journal of Experimental Medicine, vol. 168, no. 2, pp. 789–794, 1988. View at Publisher · View at Google Scholar · View at Scopus
  9. B. L. McVicker, D. J. Tuma, K. K. Kharbanda, J. L. Kubik, and C. A. Casey, “Effect of chronic ethanol administration on the in vitro production of proinflammatory cytokines by rat Kupffer cells in the presence of apoptotic cells,” Alcoholism: Clinical and Experimental Research, vol. 31, no. 1, pp. 122–129, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Vera and N. Nieto, “Hepatic stellate cells and alcoholic liver disease,” Revista Espanola de Enfermedades Digestivas, vol. 98, no. 9, pp. 674–684, 2006. View at Google Scholar · View at Scopus
  11. T. Andus, J. Bauer, and W. Gerok, “Effects of cytokines on the liver,” Hepatology, vol. 13, no. 2, pp. 364–375, 1991. View at Publisher · View at Google Scholar · View at Scopus
  12. J. V. Castell, T. Geiger, V. Gross et al., “Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte-stimulating factor in the rat,” European Journal of Biochemistry, vol. 177, no. 2, pp. 357–361, 1988. View at Google Scholar
  13. J. G. Chabot, P. Walker, and G. Pelletier, “Distribution of epidermal growth factor binding sites in the adult rat liver,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 250, no. 6, pp. G760–G764, 1986. View at Google Scholar · View at Scopus
  14. B. L. Ferraiolo, J. A. Moore, D. Crase, P. Gribling, H. Wilking, and R. A. Baughman, “Pharmacokinetics and tissue distribution of recombinant human tumor necrosis factor-α in mice,” Drug Metabolism and Disposition, vol. 16, no. 2, pp. 270–275, 1988. View at Google Scholar · View at Scopus
  15. M. A. Hartshorn, C. D. Scott, and R. C. Baxter, “Immunofluorescent localization of type II insulin-like growth factor receptor in rat liver and hepatoma cells,” Journal of Endocrinology, vol. 121, no. 2, pp. 221–227, 1989. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Kato, Y. Kato, T. Nakamura, and Y. Sugiyama, “Efficient extraction by the liver governs overall elimination of hepatocyte growth factor in rats,” Journal of Pharmacology and Experimental Therapeutics, vol. 290, no. 1, pp. 373–379, 1999. View at Google Scholar · View at Scopus
  17. D. C. Kim, Y. Sugiyama, T. Fuwa, S. Sakamoto, T. Iga, and M. Hanano, “Kinetic analysis of the elimination process of human epidermal growth factor (hEGF) in rats,” Biochemical Pharmacology, vol. 38, no. 2, pp. 241–249, 1989. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Klapproth, J. Castell, T. Geiger, T. Andus, and P. C. Heinrich, “Fate and biological action of human recombinant interleukin 1β in the rat in vivo,” European Journal of Immunology, vol. 19, no. 8, pp. 1485–1490, 1989. View at Publisher · View at Google Scholar · View at Scopus
  19. O. Sonne, O. Davidsen, B. K. Moller, and C. M. Petersen, “Cellular targets and receptors for interleukin-6 in vivo and in vitro uptake of Il-6 in liver and hepatocytes,” European Journal of Clinical Investigation, vol. 20, no. 4, pp. 366–376, 1990. View at Google Scholar · View at Scopus
  20. J. Castell, J. Klapproth, V. Gross et al., “Fate of interleukin-6 in the rat. Involvement of skin in its catabolism,” European Journal of Biochemistry, vol. 189, no. 1, pp. 113–118, 1990. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Flisiak, B. Pytel-Krolczuk, and D. Prokopowicz, “Circulating transforming growth factor β1 as an indicator of hepatic function impairment in liver cirrhosis,” Cytokine, vol. 12, no. 6, pp. 677–681, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Fujimoto, M. Uemura, Y. Nakatani et al., “Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance,” Alcoholism: Clinical and Experimental Research, vol. 24, no. 4, pp. 48s–54s, 2000. View at Google Scholar · View at Scopus
  23. J. Genesca, A. Gonzalez, R. Segura et al., “Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis,” The American Journal of Gastroenterology, vol. 94, no. 1, pp. 169–177, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. A. I. Jacob, P. K. Goldberg, N. Bloom, G. A. Degenshein, and P. J. Kozinn, “Endotoxin and bacteria in portal blood,” Gastroenterology, vol. 72, no. 6, pp. 1268–1270, 1977. View at Google Scholar · View at Scopus
  25. F. Y. Lee, R. H. Lu, Y. T. Tsai et al., “Plasma interleukin-6 levels in patients with cirrhosis. Relationship to endotoxemia, tumor necrosis factor-alpha and hyperdynamic circulation,” Scandinavian Journal of Gastroenterology, vol. 31, no. 5, pp. 500–505, 1996. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Neuman, P. Angulo, I. Malkiewicz et al., “Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in promary biliary cirrhosis,” Journal of Gastroenterology and Hepatology, vol. 17, no. 2, pp. 196–202, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Odeh, E. Sabo, I. Srugo, and A. Oliven, “Serum levels of tumor necrosis factor-α correlate with severity of hepatic encephalopathy due to chronic liver failure,” Liver International, vol. 24, no. 2, pp. 110–116, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Sheron, G. Bird, J. Goka, G. Alexander, and R. Williams, “Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis,” Clinical & Experimental Immunology, vol. 84, no. 3, pp. 449–453, 1991. View at Google Scholar · View at Scopus
  29. K.-X. Liu, Y. Kato, M. Kato, T.-I. Kaku, T. Nakamura, and Y. Sugiyama, “Existence of two nonlinear elimination mechanisms for hepatocyte growth factor in rats,” American Journal of Physiology—Endocrinology and Metabolism, vol. 273, no. 5, pp. E891–E897, 1997. View at Google Scholar · View at Scopus
  30. R. Appasamy, M. Tanabe, N. Murase et al., “Hepatocyte growth factor, blood clearance, organ uptake, and biliary excretion in normal and partially hepatectomized rats,” Laboratory Investigation, vol. 68, no. 3, pp. 270–276, 1993. View at Google Scholar · View at Scopus
  31. N. Arakaki, S. Kawakami, O. Nakamura et al., “Evidence for the presence of an inactive precursor of human hepatocyte growth factor in plasma and sera of patients with liver diseases,” Hepatology, vol. 22, no. 6, pp. 1728–1734, 1995. View at Google Scholar · View at Scopus
  32. H. Inoue, F. Yokoyama, Y. Kita et al., “Relationship between the proliferative capability of hepatocytes and the intrahepatic expression of hepatocyte growth factor and c-Met in the course of cirrhosis development in rats,” International Journal of Molecular Medicine, vol. 17, no. 5, pp. 857–864, 2006. View at Google Scholar · View at Scopus
  33. S. Kawakami, H. Tsubouchi, S. Nakagawa et al., “Expression of hepatocyte growth factor in normal and carbon tetrachloride-treated monkeys,” Hepatology, vol. 20, no. 5, pp. 1255–1260, 1994. View at Google Scholar · View at Scopus
  34. K. X. Liu, Y. Kato, M. Yamazaki, O. Higuchi, T. Nakamura, and Y. Sugiyama, “Decrease in the hepatic clearance of hepatocyte growth factor in carbon tetrachloride-intoxicated rats,” Hepatology, vol. 17, no. 4, pp. 651–660, 1993. View at Publisher · View at Google Scholar · View at Scopus
  35. K.-X. Liu, Y. Kato, M. Narukawa et al., “Importance of the liver in plasma clearance of hepatocyte growth factor in rats,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 263, no. 5, pp. G642–G649, 1992. View at Google Scholar · View at Scopus
  36. G. K. Michalopoulos and R. Appasamy, “Metabolism of HGF-SF and its role in liver regeneration,” EXS, vol. 65, pp. 275–283, 1993. View at Google Scholar · View at Scopus
  37. J. Rudi, R. Waldherr, R. Raedsch, and W. Stremmel, “Serum hepatocyte growth factor levels in primary biliary cirrhosis,” European Journal of Gastroenterology and Hepatology, vol. 7, no. 11, pp. 1081–1086, 1995. View at Publisher · View at Google Scholar · View at Scopus
  38. G. Shiota, J.-I. Okano, H. Kawasaki, T. Kawamoto, and T. Nakamura, “Serum hepatocyte growth factor levels in liver diseases: clinical implications,” Hepatology, vol. 21, no. 1, pp. 106–112, 1995. View at Publisher · View at Google Scholar · View at Scopus
  39. S. J. Burwen, M. E. Barker, I. S. Goldman, G. T. Hradek, S. E. Raper, and A. L. Jones, “Transport of epidermal growth factor by rat liver: evidence for a nonlysosomal pathway,” Journal of Cell Biology, vol. 99, no. 4, pp. 1259–1265, 1984. View at Publisher · View at Google Scholar · View at Scopus
  40. R. J. St Hilaire, G. T. Hradek, and A. L. Jones, “Hepatic sequestration and biliary secretion of epidermal growth factor: evidence for a high-capacity uptake system,” Proceedings of the National Academy of Sciences of the United States of America, vol. 80, no. 12, pp. 3797–3801, 1983. View at Publisher · View at Google Scholar · View at Scopus